These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 25762287

  • 1. Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.
    Massie AB, Luo X, Alejo JL, Poon AK, Cameron AM, Segev DL.
    Liver Transpl; 2015 May; 21(5):683-9. PubMed ID: 25762287
    [Abstract] [Full Text] [Related]

  • 2. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ, Gish RG, Ahmed A.
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [Abstract] [Full Text] [Related]

  • 3. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG, Villamil FG, Lendoire JC, Tagliafichi V, Lopez A, Krogh DH, Soratti CA, Bisigniano L.
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [Abstract] [Full Text] [Related]

  • 4. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
    Marvin MR, Ferguson N, Cannon RM, Jones CM, Brock GN.
    Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
    [Abstract] [Full Text] [Related]

  • 5. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW.
    Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
    [Abstract] [Full Text] [Related]

  • 6. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [Abstract] [Full Text] [Related]

  • 7. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C, Belghiti J, Castaing D, Chazouillères O, Duclos-Vallée JC, Duvoux C, Lerut J, Le Treut YP, Moreau R, Mandot A, Pageaux G, Samuel D, Thabut D, Valla D, Durand F.
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [Abstract] [Full Text] [Related]

  • 8. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ, Lai JC, Dodge JL, Roberts JP.
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [Abstract] [Full Text] [Related]

  • 9. Serum hypoalbuminemia predicts late mortality on the liver transplant waiting list.
    Porrett PM, Baranov E, ter Horst M.
    Transplantation; 2015 Jan; 99(1):158-63. PubMed ID: 25050469
    [Abstract] [Full Text] [Related]

  • 10. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.
    Sharma P, Schaubel DE, Gong Q, Guidinger M, Merion RM.
    Hepatology; 2012 Jan; 55(1):192-8. PubMed ID: 21898487
    [Abstract] [Full Text] [Related]

  • 11. Use of MELD score in country with low organ donation.
    Limsrichamrern S, Mahawithitwong P, Sirivatanauksorn Y, Mitmanochai P.
    J Med Assoc Thai; 2013 Aug; 96(8):924-8. PubMed ID: 23991598
    [Abstract] [Full Text] [Related]

  • 12. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N, Nourijelyani K, Nasiri-Tousi M, Ghodssi-Ghassemabadi R, Azmoudeh-Ardalan F, Nedjat S.
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
    Pestana RC, Baracat EI, Massarollo PC, Pereira LA, Szutan LA.
    Transplant Proc; 2013 Feb; 45(6):2111-4. PubMed ID: 23747144
    [Abstract] [Full Text] [Related]

  • 15. Developments in pediatric liver transplantation since implementation of the new allocation rules in Eurotransplant.
    Herden U, Grabhorn E, Briem-Richter A, Ganschow R, Nashan B, Fischer L.
    Clin Transplant; 2014 Sep; 28(9):1061-8. PubMed ID: 25040668
    [Abstract] [Full Text] [Related]

  • 16. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P, Oberkofler CE, Slankamenac K, Puhan MA, Schadde E, Müllhaupt B, Geier A, Clavien PA.
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [Abstract] [Full Text] [Related]

  • 17. Serum sodium and survival benefit of liver transplantation.
    Sharma P, Schaubel DE, Goodrich NP, Merion RM.
    Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
    [Abstract] [Full Text] [Related]

  • 18. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C, Cholankeril G, Yoo ER, Hu M, Wong RJ, Ahmed A.
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [Abstract] [Full Text] [Related]

  • 19. Re-weighting the model for end-stage liver disease score components.
    Sharma P, Schaubel DE, Sima CS, Merion RM, Lok AS.
    Gastroenterology; 2008 Nov; 135(5):1575-81. PubMed ID: 18835388
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.